Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

Allergic rhinitis is a symptomatic disorder of the nose after allergen exposure by an IgE-mediated of the membranes lining the nose. It is a health problem that causes major illness and disability. Over 600 million patients from all, all ethnic groups and of all ages suffer from rhinitis. It affects social life, sleep, school and and its economic impact is substantial. factors for allergic rhinitis are well identified. and outdoor allergens as well as occupational cause rhinitis and other allergic diseases. role of indoor and outdoor pollution is probably important, but has yet to be fully understood for the occurrence of the disease and its manifestations. 1999, during the Allergic Rhinitis and its Impact on (ARIA) WHO workshop, the expert panel a new classification for allergic rhinitis which subdivided into ᵢntermittent_ or ₚersistent_ disease. classification is now validated. diagnosis of allergic rhinitis is often quite easy, but some cases it may cause problems and many patients still under-diagnosed, often because they do not the symptoms of rhinitis as a disease impairing social life, school and work. management of allergic rhinitis is well established the ARIA expert panel based its recommendations evidence using an extensive review of the literature up to December 1999. The statements of for the development of these guidelines followed rules and were based on those of Shekelle et al. large number of papers have been published since 2000 are extensively reviewed in the 2008 Update using same evidence-based system. Recommendations for management of allergic rhinitis are similar in both the workshop report and the 2008 Update. In the, the GRADE approach will be used, but is not yet. important aspect of the ARIA guidelines was consider co-morbidities. Both allergic rhinitis and are systemic inflammatory conditions and often-exist in the same patients. In the 2008 Update, these have been confirmed. is not intended to be a standard-ofcare for individual countries. It is provided as a for physicians, health care professionals and involved in the treatment of allergic rhinitis asthma in various countries to facilitate the of relevant local standard-of-care documents patients.